# Inherited Cancer Early Diagnosis (ICED) Study

> **NCT06163365** · — · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 100 (estimated)

## Conditions studied

- Li Fraumeni Syndrome
- Lynch Syndrome
- Hereditary Diffuse Gastric Cancer
- Cowden Syndrome
- Peutz-Jeghers Syndrome
- Familial Adenomatous Polyposis
- SMAD4 Gene Mutation
- MutYH-associated Polyposis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06163365
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-26
- **Primary completion:** 2024-07-26
- **Final completion:** 2025-07-26
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06163365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06163365, "Inherited Cancer Early Diagnosis (ICED) Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06163365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*